Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jupiter Neurosciences (JUNS) Cash from Financing Activities (2024)

Jupiter Neurosciences (JUNS) has disclosed Cash from Financing Activities for 1 consecutive years, with $7.5 million as the latest value for Q4 2024.

  • Quarterly Cash from Financing Activities changed N/A to $7.5 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $7.7 million through Dec 2024, changed N/A year-over-year, with the annual reading at $5.4 million for FY2025, 28.99% down from the prior year.
  • Cash from Financing Activities for Q4 2024 was $7.5 million at Jupiter Neurosciences, up from $28000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $7.5 million in Q4 2024, with the low at $28000.0 in Q3 2024.